Another study reported that small molecule (BI2536)-mediated inhibition of PLK-1 potentiates the anticancer activity of metformin (oxidative phosphorylation and mTORC1 inhibitor) in prostate cancer cells [94]. The gene discussed is PLK1; the disease is prostate carcinoma.